Dilvin Semo

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Polycystic Ovary Syndrome

Aortic Stenosis

Top Venues

Signal transduction and targeted therapy

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dilvin Semo, Holger Reinecke, Rinesh Godfrey
Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity. Signal transduction and targeted therapy 9 (1) (2024)
Dilvin Semo, Holger Reinecke, Rinesh Godfrey
Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity. Signal transduction and targeted therapy 9 (1) (2024)
Dilvin Semo, Holger Reinecke, Rinesh Godfrey
Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity. Signal transduction and targeted therapy 9 (1) (2024)
Dilvin Semo, Holger Reinecke, Rinesh Godfrey
Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity. Signal transduction and targeted therapy 9 (1) (2024)
Bernhard Ohnewein, Zornitsa Shomanova, Vera Paar, Albert Topf, Peter Jirak, Lukas Fiedler, Christina Granitz, Vincent Van Almsick, Dilvin Semo, Naufal Shamilevich Zagidullin, Anna-Maria Dieplinger, Juergen Sindermann, Holger Reinecke, Uta C Hoppe, Rudin Pistulli, Lukas J Motloch
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine. Journal of clinical medicine 12 (9) (2023)
Bernhard Ohnewein, Zornitsa Shomanova, Vera Paar, Albert Topf, Peter Jirak, Lukas Fiedler, Christina Granitz, Vincent Van Almsick, Dilvin Semo, Naufal Shamilevich Zagidullin, Anna-Maria Dieplinger, Juergen Sindermann, Holger Reinecke, Uta C Hoppe, Rudin Pistulli, Lukas J Motloch
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine. Journal of clinical medicine 12 (9) (2023)